High Thermostability and Lack of Cooperative DNA Binding Distinguish the p63 Core Domain from the Homologous Tumor Suppressor p53*
暂无分享,去创建一个
R. Huber | C. Klein | Christian Klein | R. Engh | G. Georges | K. Künkele | S. Hansen | K. Künkele
[1] H. Edelhoch,et al. Spectroscopic determination of tryptophan and tyrosine in proteins. , 1967, Biochemistry.
[2] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[3] R. Doolittle,et al. A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.
[4] W. Kabsch,et al. Dictionary of protein secondary structure: Pattern recognition of hydrogen‐bonded and geometrical features , 1983, Biopolymers.
[5] A. Levine,et al. Two distinct mechanisms regulate the levels of a cellular tumor antigen, p53 , 1983, Molecular and cellular biology.
[6] W. Maltzman,et al. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells , 1984, Molecular and cellular biology.
[7] C. Pace. Determination and analysis of urea and guanidine hydrochloride denaturation curves. , 1986, Methods in enzymology.
[8] R Langridge,et al. Improvements in protein secondary structure prediction by an enhanced neural network. , 1990, Journal of molecular biology.
[9] M. W. Pandit,et al. Correlation between stability of a protein and its dipeptide composition: a novel approach for predicting in vivo stability of a protein from its primary sequence. , 1990, Protein engineering.
[10] B. Vogelstein,et al. p53 mutations in human cancers. , 1991, Science.
[11] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[12] D. Lane,et al. Regulation of the specific DNA binding function of p53 , 1992, Cell.
[13] K. Kinzler,et al. Definition of a consensus binding site for p53 , 1992, Nature Genetics.
[14] J. Shay,et al. A transcriptionally active DNA-binding site for human p53 protein complexes , 1992, Molecular and cellular biology.
[15] G. Böhm,et al. Quantitative analysis of protein far UV circular dichroism spectra by neural networks. , 1992, Protein engineering.
[16] C. Pabo,et al. The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. , 1993, Genes & development.
[17] J. E. Stenger,et al. p53 domains: identification and characterization of two autonomous DNA-binding regions. , 1993, Genes & development.
[18] X. Chen,et al. A proteolytic fragment from the central region of p53 has marked sequence-specific DNA-binding activity when generated from wild-type but not from oncogenic mutant p53 protein. , 1993, Genes & development.
[19] A. Fersht,et al. Engineered disulfide bonds as probes of the folding pathway of barnase: increasing the stability of proteins against the rate of denaturation. , 1993, Biochemistry.
[20] P. Jeffrey,et al. Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.
[21] R D Appel,et al. A new generation of information retrieval tools for biologists: the example of the ExPASy WWW server. , 1994, Trends in biochemical sciences.
[22] J. Thompson,et al. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.
[23] C. Arrowsmith,et al. Solution structure of the tetrameric minimum transforming domain of p53 , 1995, Nature Structural Biology.
[24] P. Tegtmeyer,et al. Interaction of p53 with its consensus DNA-binding site , 1995, Molecular and cellular biology.
[25] G. Marius Clore,et al. Refined solution structure of the oligomerization domain of the tumour suppressor p53 , 1995, Nature Structural Biology.
[26] T. Halazonetis,et al. The dihedral symmetry of the p53 tetramerization domain mandates a conformational switch upon DNA binding. , 1995, The EMBO journal.
[27] P. Tegtmeyer,et al. Role of cysteine residues in regulation of p53 function , 1995, Molecular and cellular biology.
[28] A A Salamov,et al. Prediction of protein secondary structure by combining nearest-neighbor algorithms and multiple sequence alignments. , 1995, Journal of molecular biology.
[29] A. Gronenborn,et al. Four p53 DNA-binding domain peptides bind natural p53-response elements and bend the DNA. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[30] N. Pavletich,et al. Crystal structure of the tetramerization domain of the p53 tumor suppressor at 1.7 angstroms , 1995, Science.
[31] N. Pavletich,et al. Structure of the p53 Tumor Suppressor Bound to the Ankyrin and SH3 Domains of 53BP2 , 1996, Science.
[32] T. Soussi,et al. Structural aspects of the p53 protein in relation to gene evolution: a second look. , 1996, Journal of molecular biology.
[33] D. Lane,et al. Allosteric Regulation of the Thermostability and DNA Binding Activity of Human p53 by Specific Interacting Proteins (*) , 1996, The Journal of Biological Chemistry.
[34] C. Arrowsmith,et al. New insights into p53 function from structural studies. , 1996, Oncogene.
[35] T. Halazonetis,et al. Structure–based rescue of common tumor–derived p53 mutants , 1996, Nature Medicine.
[36] Thomas L. Madden,et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.
[37] A. Yang,et al. Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.
[38] M. Oren,et al. Mdm2 promotes the rapid degradation of p53 , 1997, Nature.
[39] V. Zhurkin,et al. Architectural Accommodation in the Complex of Four p53 DNA Binding Domain Peptides with the p21/waf1/cip1 DNA Response Element* , 1997, The Journal of Biological Chemistry.
[40] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[41] W. Kaelin,et al. p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.
[42] A. Fersht,et al. Thermodynamic stability of wild-type and mutant p53 core domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[43] A. Levine. p53, the Cellular Gatekeeper for Growth and Division , 1997, Cell.
[44] C. Bamberger,et al. A novel protein with strong homology to the tumor suppressor p53 , 1997, Oncogene.
[45] A. Fersht,et al. Semirational design of active tumor suppressor p53 DNA binding domain with enhanced stability. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[46] J. Boeke,et al. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations , 1998, The EMBO journal.
[47] K. McLure,et al. How p53 binds DNA as a tetramer , 1998, The EMBO journal.
[48] A. Yang,et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.
[49] Chikashi Ishioka,et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53 , 1998, Nature Medicine.
[50] J. Jen,et al. A new human p53 homologue , 1998, Nature Medicine.
[51] C. Prives. Signaling to p53 Breaking the MDM2–p53 Circuit , 1998, Cell.
[52] Xinbin Chen,et al. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. , 1998, Cancer research.
[53] H. Kato,et al. A second p53-related protein, p73L, with high homology to p73. , 1998, Biochemical and biophysical research communications.
[54] H. Vogel,et al. p63 is a p53 homologue required for limb and epidermal morphogenesis , 1999, Nature.
[55] B. Foster,et al. Pharmacological rescue of mutant p53 conformation and function. , 1999, Science.
[56] D. Xirodimas,et al. Molecular Evolution of the Thermosensitive PAb1620 Epitope of Human p53 by DNA Shuffling* , 1999, The Journal of Biological Chemistry.
[57] C. Arrowsmith,et al. Solution structure of a conserved C‐terminal domain of p73 with structural homology to the SAM domain , 1999, The EMBO journal.
[58] K. Kinzler,et al. Identification and classification of p53-regulated genes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[59] M Bycroft,et al. Hot-spot mutants of p53 core domain evince characteristic local structural changes. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[60] Michael Bamshad,et al. Heterozygous Germline Mutations in the p53 Homolog p63 Are the Cause of EEC Syndrome , 1999, Cell.
[61] S. Kato,et al. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. , 1999, Cancer research.
[62] C. Prives,et al. p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells , 1999, Molecular and Cellular Biology.
[63] W. Kaelin. The p53 gene family , 1999, Oncogene.
[64] C. Arrowsmith. Structure and function in the p53 family , 1999, Cell Death and Differentiation.
[65] G. Melino,et al. Structure, function and regulation of p63 and p73 , 1999, Cell Death and Differentiation.
[66] Margaret Ashcroft,et al. Regulation of p53 stability , 1999, Oncogene.
[67] Christopher P. Crum,et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development , 1999, Nature.
[68] A. Ellington,et al. In vitro evolution of thermostable p53 variants , 2008, Protein science : a publication of the Protein Society.
[69] B. Kennedy,et al. NPAT links cyclin E-Cdk2 to the regulation of replication-dependent histone gene transcription. , 2000, Genes & development.
[70] V. Rotter,et al. Oncogenic mutations of the p53 tumor suppressor: the demons of the guardian of the genome. , 2000, Cancer research.
[71] A. Yang,et al. p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours , 2000, Nature.
[72] A. Yang,et al. p63 and p73: p53 mimics, menaces and more , 2000, Nature Reviews Molecular Cell Biology.
[73] K. Vousden,et al. Regulation and function of the p53-related proteins: same family, different rules. , 2000, Trends in cell biology.
[74] A. Fersht,et al. Mechanism of rescue of common p53 cancer mutations by second‐site suppressor mutations , 2000, The EMBO journal.
[75] A. Fersht,et al. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy , 2000, Oncogene.
[76] P. Hainaut,et al. Redox signalling and transition metals in the control of the p53 pathway. , 2000, Biochemical pharmacology.
[77] K. Vousden,et al. Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .
[78] F. McKeon,et al. An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. , 2000, Science.
[79] J. Jen,et al. AIS is an oncogene amplified in squamous cell carcinoma. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[80] G Melino,et al. The p53/p63/p73 family of transcription factors: overlapping and distinct functions. , 2000, Journal of cell science.
[81] A. Levine,et al. Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73* , 2000, The Journal of Biological Chemistry.
[82] R. Jaenicke,et al. Stability and stabilization of globular proteins in solution. , 2000, Journal of biotechnology.
[83] Xiaoqi Wang,et al. MDM2 and MDMX can interact differently with ARF and members of the p53 family , 2001, FEBS letters.
[84] J. Manfredi,et al. The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX Promoter* , 2001, The Journal of Biological Chemistry.
[85] B. Trink,et al. p53 associates with and targets ΔNp63 into a protein degradation pathway , 2001 .
[86] R. Marmorstein,et al. Crystal Structure of the Mouse p53 Core DNA-binding Domain at 2.7 Å Resolution* , 2001, The Journal of Biological Chemistry.
[87] G. Blandino,et al. From p63 to p53 across p73 , 2001, FEBS letters.
[88] Yu Wai Chen,et al. Structure of the C-terminal sterile α-motif (SAM) domain of human p73α , 2001 .
[89] C. Prives,et al. A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain , 2001, Molecular and Cellular Biology.